KDR and neoplasm: VEGFR2 (vascular endothelial growth factor receptor 2), the major VEGF-A receptor involved in aniogenesis and vasculogenesis, and PD-L1, expressed in 64.5% and 35.5% of cells from OS, respectively, were associated with a prometastatic effect on lung and tumor growth [294,295].